• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Regenerx Biopharmaceuticals Inc. (RGRX)

    -Other OTC
    0.24 Down 0.02(8.08%) Feb 27, 3:47PM EST
    |Pre-Market : NaN
    Add to Portfolio
    Prev Close:0.27
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:0.50
    Beta:0.7
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.10 - 0.28
    Volume:0
    Avg Vol (3m):87,866
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RGRX

    Comparison

    Symbol% ChgMkt Cap
    RGRXDown 8.08%N/A
    ASTM 0.00%N/A
    JNJDown 0.28%285.03B
    NVSDown 0.58%238.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of molecules for tissue and organ repair. The company develops its product candidates based on Thymosin beta 4 (Tß4), an amino acid peptide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback